Gun Ei Chemical Industry (4229) Q1 2027 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2027 earnings summary
30 Jul, 2026Executive summary
Net sales rose 9.2% year-over-year to ¥8,435 million for the quarter ended June 30, 2026.
Operating profit increased 58.6% year-over-year to ¥1,033 million.
Ordinary profit grew 56.5% year-over-year to ¥1,138 million.
Profit attributable to owners of parent declined 18.0% year-over-year to ¥379 million.
Comprehensive income surged to ¥2,970 million from ¥587 million a year earlier.
Financial highlights
Gross profit improved to ¥2,186 million from ¥1,731 million year-over-year.
Basic earnings per share was ¥57.26, down from ¥69.90 year-over-year.
Total assets increased to ¥72,570 million as of June 30, 2026, up from ¥68,012 million at March 31, 2026.
Net assets rose to ¥59,377 million from ¥56,853 million at the previous fiscal year-end.
Outlook and guidance
Full-year net sales forecast at ¥34,200 million, up 9.2% year-over-year.
Full-year operating profit projected at ¥2,600 million, up 1.3% year-over-year.
Full-year profit attributable to owners of parent expected to decline 13.9% to ¥1,700 million.
Basic earnings per share forecast at ¥256.18 for the full year.
Dividend forecast revised to ¥120.00 per share, including a commemorative dividend.
Latest events from Gun Ei Chemical Industry
- Profit surged in H1 as pricing and environmental materials offset weak electronics demand.4229
Q2 2024 - Profit rebounded sharply, but FY25 guidance anticipates margin pressure amid major capacity investment.4229
Q4 2024 - Quarterly sales and profits declined year-over-year, with lower full-year profit guidance.4229
Q1 2025 - Sales and profits fell year-over-year, with profit margins under pressure despite strong equity.4229
Q3 2025 - H1 earnings fell, but semiconductor strength lifted profit guidance as the sales outlook was cut.4229
Q2 2025 - Sales rose, operating profit fell, and FY2031 targets include ¥40 billion operating profit.4229
Q4 2025 - Sales rose slightly, but profits declined; full-year outlook expects lower earnings.4229
Q1 2026 - H1 sales and operating profit rose, while net profit edged lower and FY guidance held.4229
Q2 2026 - FY26 earnings and comprehensive income rose; FY27 guidance remains uncertain.4229
Q4 2026